Gliocladium
Genus of fungi
Gliocladium is a genus of fungi in the family Hypocreaceae. This genus is known for its role in biological control and its ability to produce secondary metabolites with potential applications in agriculture and medicine. Gliocladium species are commonly found in soil and on decaying plant material.
Taxonomy[edit]
Gliocladium was first described by the mycologist Charles H. Peck in 1879. The genus is characterized by its production of conidia in slimy heads, which are borne on phialides that arise from a well-developed stipe. The conidia are typically one-celled, hyaline, and smooth-walled.
Species[edit]
Several species of Gliocladium have been identified, including:
- Gliocladium roseum
- Gliocladium virens (now reclassified as Trichoderma virens)
- Gliocladium penicillioides
Biological Control[edit]
Gliocladium species, particularly Gliocladium virens, are known for their use in biological control of plant pathogens. They act as mycoparasites, attacking and parasitizing other fungi, including those that cause plant diseases. This makes them valuable in agriculture for the control of soil-borne pathogens such as Rhizoctonia solani and Sclerotium rolfsii.
Secondary Metabolites[edit]
Gliocladium species produce a variety of secondary metabolites that have been studied for their potential use in medicine and agriculture. These compounds include antibiotics, antifungal agents, and enzymes that degrade plant cell walls.
Ecology[edit]
Gliocladium species are commonly found in soil and on decaying plant material. They play a role in the decomposition of organic matter and the recycling of nutrients in ecosystems. They are also found in association with plant roots, where they may form beneficial relationships.
Related Pages[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
